Macrogenics Inc (NASDAQ: MGNX) kicked off on Monday, down -4.83% from the previous trading day, before settling in for the closing price of $3.52. Over the past 52 weeks, MGNX has traded in a range of $3.14-$21.88.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 15.77% over the past five years. While this was happening, its average annual earnings per share was recorded -1203.39%. With a float of $58.54 million, this company’s outstanding shares have now reached $62.07 million.
Let’s look at the performance matrix of the company that is accounted for 339 employees.
Macrogenics Inc (MGNX) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Macrogenics Inc is 6.66%, while institutional ownership is 102.82%. The most recent insider transaction that took place on Apr 04 ’24, was worth 799,148. In this transaction Senior VP and General Counsel of this company sold 51,395 shares at a rate of $15.55, taking the stock ownership to the 0 shares. Before that another transaction happened on Mar 06 ’24, when Company’s Senior VP and General Counsel sold 19,625 for $21.50, making the entire transaction worth $421,938. This insider now owns 8,895 shares in total.
Macrogenics Inc (MGNX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.72 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -1203.39% per share during the next fiscal year.
Macrogenics Inc (NASDAQ: MGNX) Trading Performance Indicators
Take a look at Macrogenics Inc’s (MGNX) current performance indicators. Last quarter, stock had a quick ratio of 2.69. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.19, a number that is poised to hit 0.23 in the next quarter and is forecasted to reach -2.19 in one year’s time.
Technical Analysis of Macrogenics Inc (MGNX)
Macrogenics Inc (NASDAQ: MGNX) saw its 5-day average volume 0.77 million, a negative change from its year-to-date volume of 1.81 million. As of the previous 9 days, the stock’s Stochastic %D was 9.93%. Additionally, its Average True Range was 0.41.
During the past 100 days, Macrogenics Inc’s (MGNX) raw stochastic average was set at 1.28%, which indicates a significant decrease from 3.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 145.27% in the past 14 days, which was lower than the 258.95% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.46, while its 200-day Moving Average is $10.11. Nevertheless, the first resistance level for the watch stands at $3.46 in the near term. At $3.58, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.63. If the price goes on to break the first support level at $3.29, it is likely to go to the next support level at $3.24. Assuming the price breaks the second support level, the third support level stands at $3.12.
Macrogenics Inc (NASDAQ: MGNX) Key Stats
The company with the Market Capitalisation of 210.11 million has total of 62,633K Shares Outstanding. Its annual sales at the moment are 58,750 K in contrast with the sum of -9,060 K annual income. Company’s last quarter sales were recorded 9,100 K and last quarter income was -52,190 K.
